CNPR FDA Regulations 4

Question 1

Which of the following best describes 'Accelerated Approval' under FDA regulations?

Accepted Answer

Approval based on a surrogate endpoint reasonably likely to predict clinical benefit, with confirmatory trials required

Answer

Accelerated Approval allows the FDA to approve drugs based on surrogate endpoints (like tumor shrinkage) while requiring manufacturers to conduct confirmatory trials proving actual clinical benefit.

Question 2

Under the Controlled Substances Act (CSA), which DEA schedule includes drugs with accepted medical use but the highest potential for abuse, such as oxycodone and fentanyl?

Accepted Answer

Schedule II

Answer

Schedule II drugs have a high potential for abuse, are currently accepted for medical use, and may lead to severe psychological or physical dependence.

Question 3

What is the primary role of the FDA's MedWatch program?

Accepted Answer

Voluntary and mandatory reporting of serious adverse events and product problems

Answer

MedWatch is the FDA's Safety Information and Adverse Event Reporting Program, allowing healthcare professionals and consumers to report problems with drugs and medical products.

Question 4

A pharmaceutical company's promotional piece claims their drug is 'safe' without qualification. How does FDA view this claim?

Accepted Answer

Misleading, because no drug is completely safe and such claims must be qualified

Answer

FDA considers unqualified safety claims misleading because all drugs carry some risk, and such claims create a false impression about the drug's risk profile.

Question 5

The Drug Supply Chain Security Act (DSCSA) requires pharmaceutical manufacturers to implement which key capability by 2023?

Accepted Answer

Serialized tracking and tracing of prescription drug packages through the supply chain

Answer

DSCSA mandates a serialized, electronic system to track and trace prescription drug packages through the entire supply chain to prevent counterfeiting and diversion.

(CNPR) Certified National Pharmaceutical Representative Practice Test

(CNPR) Certified National Pharmaceutical Representative Practice Test

CNPR FDA Regulations 4